Primary systemic chemotherapy in stage II-IIIb breast cancer: Independent prognostic value of molecular phenotype and the MDACC residual cancer burden—A single-institutional experience
Aguirre Ortega, E. M., Taberner Bonastre, M., Morales Murillo, S., Iglesias Martinez, E., Canosa Morales, C., Pon Cladera, M. L., Carceller Vidal, J. A., Marquez-Medina, D., Panades Siurana, M. J., Vilardell Villellas, F., Gonzalez Falco, S., Garcia Reglero, V., Llombart Cussac, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article